Multiple sclerosis and related disordersHumansFemaleMaleAdultIran
Hypogammaglobulinemia and infection risks in multiple sclerosis patients receiving anti-CD20 monoclonal antibodies: Incidence, clinical implications, and longitudinal insights from a three-year Iranian cohort.
Elham Asl Fallah, Ali Emami, Nahid Beladi Moghaddam, Mehran Ghaffari, Fatemeh Meshkini, Sepideh Paybast
Published: 202610.1016/j.msard.2025.106887
Abstract
INTRODUCTION: Anti-CD20 monoclonal antibodies are regarded as high efficacy disease-modifying therapy (DMT) for management of multiple sclerosis (MS). However, prolonged B-cell depletion might increase the risk of secondary hypogammaglobulinemia (SHG…
Preview only. Read the full abstract at the source